Ralf Brandt
Vermögen: 108 406 $ am 31.08.2026
Vermögen: 108 406 $ am 31.08.2026
Ralf Brandt was the founder of vivoPharm Pty Ltd., founded in 2003, where the title held was President-Discovery & Early Development.
Current jobs include Director at Propanc Biopharma, Inc. starting in 2026, and Member-Scientific Advisory Board at Receptors, Inc. Former jobs include President-Discovery & Early Development at Cancer Genetics, Inc., Principal at National Cancer Institute, and President-Discovery & Early Development Services at Vyant Bio, Inc. Education includes a doctorate conferred in 1991 and an undergraduate degree conferred in 1986, both from Martin-Luther-Universität Halle-Wittenberg.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PROPANC BIOPHARMA INC 2,29 % | 23.09.2026 | 80 301 ( 2,29 % ) | 108 406 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 20.02.2026 |
Receptors, Inc.
Receptors, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures electrical equipment and supplies | Corporate Officer/Principal | 02.06.2011 |
| Unternehmen | Position | Ende |
|---|---|---|
| VYANT BIO, INC. | Corporate Officer/Principal | 31.12.2022 |
vivoPharm Pty Ltd.
vivoPharm Pty Ltd. BiotechnologyHealth Technology Provides proprietary preclinical oncology services | Gründer | 01.08.2017 |
| CANCER GENETICS, INC. | Corporate Officer/Principal | - |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Propanc Biopharma, Inc.
Propanc Biopharma, Inc. BiotechnologyHealth Technology Operates as a development stage healthcare company which develops new cancer treatments for patients | Health Technology |
Receptors, Inc.
Receptors, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures electrical equipment and supplies | Electronic Technology |
Cancer Genetics, Inc.
Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Provides cancer diagnostics and clinical services | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Martin-Luther-Universität Halle-Wittenberg
Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vivoPharm Pty Ltd.
vivoPharm Pty Ltd. BiotechnologyHealth Technology Provides proprietary preclinical oncology services | Health Technology |
Vyant Bio, Inc.
Vyant Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen